Promising Urine Malaria Test

This article, by Jaci Arthur for the Innovate4Health initiative, presents a patented urine malaria test that was developed by Dr. David Sullivan, a Johns Hopkins Bloomberg School of Public Health professor and microbiologist. The test, which offers a rapid, accurate, more convenient, and less expensive alternative to traditional laboratory testing, is the first point of care diagnosic test for malaria that does not require the use of trained personnel or a blood sample. Expeditious diagnosis of malaria can result in faster treatment and lower mortality rates. Fyodor Biotechnologies, a US company established in 2008 by Nigerian biotechnologist Eddy Agbo, was granted an exclusive worldwide license from Johns Hopkins University to research, develop, and commercialize the urine malaria test. The test is currently in clinical validation, after which Dr Agbo expects it will be commercialized starting in Nigeria (home to 25 per cent of malaria cases) then extending to other African markets.